Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study reported that ZSYY001, a nanoparticle formulation of polymeric micellar paclitaxel, showed promising antitumor activity and was safe and well-tolerated in preclinical models and a phase I trial, without acute hypersensitivity reactions at doses up to 390 mg/m².

This study found that among Large White × Min pigs, 15 significant copy number variation regions were associated with villi hair traits, and identified candidate genes potentially linked to cold resistance, suggesting implications for breeding cold-resistant pigs.

This review discusses the role of proteomics in understanding skin diseases such as cancers and psoriasis, with findings suggesting cell death and metabolism as major areas of focus, but reports no new experimental results.

This study reviews the complex keratinization process in the epidermis, detailing how various factors regulate keratinocyte differentiation and emphasizing the importance of understanding this process for the pathogenesis of skin disorders like ichthyoses and psoriasis.

This study found that in vitro extracts of Glycyrrhiza glabra root are strong antioxidants, particularly in ethanolic form, and contain secondary metabolites, but only showed mild antibacterial activity.

This study identified key proteins, such as Sfrp1 and Ppard, involved in the complex and dynamic regulation of yak hair follicle growth and degeneration across different stages, offering insights into yaks' adaptation to highland environments.

This article outlines methods to study the skin and its molecular traits, focusing on interpretation and techniques applicable to mouse models, including diverse assays and approaches like electron microscopy and large-scale lipid analyses.

This study found that public interest in "COVID hair loss," "telogen effluvium," and "hair loss" increased in the U.S. since mid-March, particularly in states with early COVID-19 case surges.

The patches could quickly deliver epilepsy treatment and reduce seizures.

A specific gene variant is linked to heart disease, increased heart muscle, curly hair, and thick skin on palms and soles.

In this study, researchers successfully scaled a plant-based shampoo formulation for dry and damaged hair from laboratory to industrial production, maintaining its physicochemical properties and microbiological safety throughout, highlighting the formulation's scalability and the importance of quality control in cosmetic manufacturing.

This review reports that the monosaccharide composition of polysaccharides significantly impacts their bioactivity, highlighting various roles for glucans, galactans, mannans, fructans, and pectin in immune regulation, antioxidant effects, and other biological functions.

In this pilot study, preliminary data suggest that Xtressé™, a gummy-based supplement, may increase hair count and hair mass, particularly in women experiencing female pattern hair loss or early-stage scarring alopecia, with less pronounced effects observed in advanced scarring conditions.

In this study, a patient with severe alopecia areata showed significant hair regrowth after 15 months of partial response to baricitinib and oral minoxidil, following the addition of dupilumab to their treatment regimen.

In this case study, a 64-year-old female with breast cancer undergoing ADC therapy experienced significant hair regrowth using oral minoxidil, suggesting its potential as a treatment for ADC-induced alopecia.

This study found that most TikTok content on platelet-rich plasma is created by laypeople and non-physician health care providers, and overall video quality is very poor, with content from dermatologists and physicians scoring higher.

In this study, researchers found that patients with severe alopecia areata who respond to baricitinib treatment within six months may improve clinically within a year, while those with very severe disease may require at least a year for evidence of treatment effect.

This study of baricitinib in adults with severe alopecia areata found that after initial success, 10.9% of participants lost treatment response by Week 152. Factors like longer disease duration and severe baseline symptoms were more common in those losing response.

This case series suggests that a nutraceutical gummy may effectively promote hair regrowth and reduce hair shedding in women with female pattern hair loss and telogen effluvium.

This study highlighted that diagnostic complexities can lead to misdiagnosis of alopecia areata in Black patients, commonly due to similar presentations of scarring alopecias and multiple hair loss types co-occurring within a single patient.

This study reports that ritlecitinib was prescribed to a diverse group of patients, including adolescents and adults with and without prior treatment for Alopecia Areata, in the first three months after FDA approval, potentially expanding care options for this condition.

In this study, NH Asian alopecia areata patients reported the highest levels of severe disease, with NH White patients having the most eyebrow involvement and Hispanic patients showing the least severity.

This study found that generic quality of life questionnaires, like the SF-36 and DLQI, are not sensitive enough to detect differences in health-related quality of life between patients with varying severity of alopecia areata.

This case report highlights the successful treatment of a 37-year-old male with steroid-resistant beard alopecia areata using baricitinib, a JAK-1/2 inhibitor, over 9 months, resulting in reduced hair loss and improved hair density.

In this study, a strong positive correlation was found between clinician-reported and patient-reported measures for assessing eyebrow and eyelash hair loss in patients with severe alopecia areata, indicating high agreement during treatment with baricitinib over 52 weeks.

This study found that at Week 52, baricitinib resulted in significant hair regrowth for many patients with severe alopecia areata, with 41.6% on the higher dose achieving substantial improvement in scalp hair loss, though some may need longer treatment for optimal benefit.

This study found that more than half of patients with severe alopecia areata who reduced their baricitinib dose from 4mg to 2mg maintained a clinical response for up to 2 years.

This study found that in 18 Disney live-action movies, film antagonists were depicted with significantly more dermatologic features, such as periorbital hyperpigmentation and nasolabial folds, compared to protagonists, suggesting filmmakers continue to use skin findings to portray characters as 'bad'.

In this observational study, nine out of ten patients developed Telogen Effluvium after mild COVID-19 symptoms, with hair shedding starting on average 73 days following infection.